CLGM
BIIB icon

Capitolis Liquid Global Markets’s Biogen BIIB Stock Holding History

Capitolis Liquid Global Markets’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-54,000
Closed -$14M – 119
2023
Q4 		$14M Buy
+54,000
New +$13.3M 0.57% 36

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capitolis Liquid Global Markets's BIIB Position: Q1 2024 in Review

Capitolis Liquid Global Markets sold out of Biogen (BIIB) in Q1 2024, closing a stake of 54,000 shares — an estimated $14M sold.

Capitolis Liquid Global Markets first reported a position in BIIB in Q4 2023 and held it in 1 quarter. The position peaked at $14M in Q4 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Capitolis Liquid Global Markets reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Capitolis Liquid Global Markets sold 54,000 Biogen shares in Q1 2024, an estimated $14M.
  • Capitolis Liquid Global Markets first reported a position in Biogen in Q4 2023 and held it in 1 quarter.
  • Capitolis Liquid Global Markets's Biogen position peaked at $14M in Q4 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2024, filed 13 May 2024.